c-MYC amplification and c-myc protein expression in pancreatic acinar cell carcinomas. New insights into the molecular signature of these rare cancers
Stefano La Rosa(University of Insubria), Fausto Sessa(University of Insubria), Amedeo Sciarra(University of Lausanne), Kenji Notohara(Kurashiki Central Hospital), Paola Billo(Azienda Ospedaliera Ospedale Civile di Legnano), Barbara Bernasconi(Ospedale di Circolo e Fondazione Macchi), Selenia Casnedi(Hôpital d'Hautepierre), Lizhi Zhang(Dalian Maritime University), Luca Albarello(University of Insubria), Maria Grazia Tibiletti(University of Insubria), Alessandro Vanoli(University of Pavia)
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
May 2, 2018
Cited by 30
Related Papers
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
|Genetics in Medicine|2019|666
Long-Term Survival After Pancreatoduodenectomy for Pancreatic Adenocarcinoma
|Annals of Surgery|2008|461
Immunomodulatory Function of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Type 1 Diabetes
|The Journal of Immunology|2009|383
Diagnosis of IgG4-Related Tubulointerstitial Nephritis
|Journal of the American Society of Nephrology|2011|374
Role of hepatic STAT3 in brain-insulin action on hepatic glucose production
|Cell Metabolism|2006|294